Breast Cancer at ASCO 2016

Breast cancer was a big topic of discussion at ASCO 2016. The number of tweets about breast cancer increased 177% over 2015. MA-17R was the most discussed clinical trial. Trastuzumab dominated product mentions in the breast cancer space.


 

Download this infographic.